Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
04/24/2007 | US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
04/24/2007 | CA2197793C New multimerizing agents |
04/19/2007 | WO2007044169A1 Processes for the production of hydroxyalkylmaleimides |
04/19/2007 | WO2007043677A1 Hydrazide compound and pesticidal use of the same |
04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
04/19/2007 | WO2007042250A1 Prolinamide derivatives as sodium channel modulators |
04/19/2007 | WO2007042240A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
04/19/2007 | WO2007042239A1 Prolinamide derivatives as sodium channel modulators |
04/19/2007 | WO2007041837A1 Cathepsin cysteine protease inhibitors |
04/19/2007 | WO2007024833B1 Anthranilamides for controlling invertebrate pests |
04/19/2007 | WO2007020502A3 Cannabinoid receptor ligands and uses thereof |
04/19/2007 | WO2007009389A3 Substituted propanamide derivatives, preparation and use thereof |
04/19/2007 | WO2006131340A3 Pyrrolones that act as peptide deformylase (pdf) inhibitors |
04/19/2007 | WO2006116157A3 Dipeptidyl peptidase-iv inhibitors |
04/19/2007 | WO2005054186A3 Methods for the preparation of stereoisomerically enriched amines |
04/19/2007 | US20070088165 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
04/19/2007 | US20070088058 3-(1(S)(4-chlorobenzyl)-2(S)-((2-hydroxy-2-methyl-1-phenylpropyl)amino)propyl)-benzonitrile; obesity; potentiation; antagonists |
04/19/2007 | DE10307725B4 Korrosions-und Gashydratinhibitoren mit verbesserter Wasserlöslichkeit und erhöhter biologischer Abbaubarkeit Corrosion and gas hydrate inhibitors with improved water solubility and increased biodegradability |
04/19/2007 | CA2625763A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels |
04/19/2007 | CA2625642A1 Prolinamide derivatives as sodium channel modulators |
04/19/2007 | CA2624719A1 Cathepsin cysteine protease inhibitors |
04/19/2007 | CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
04/19/2007 | CA2623202A1 Hydrazide compound and pesticidal use of the same |
04/18/2007 | EP1775286A1 Novel anandamide amidase inhibitors as analgesic agents |
04/18/2007 | EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
04/18/2007 | EP1773780A2 Amido compounds and their use as pharmaceuticals |
04/18/2007 | EP1773769A1 Salt forms of atorvastatin |
04/18/2007 | EP1773768A2 Pyrrole derivatives as pharmaceutical agents |
04/18/2007 | EP1773767A2 Syntheis of azo bonded immunoregulatory compounds |
04/18/2007 | EP1773766A2 Iap binding compounds |
04/18/2007 | EP1773763A1 Lysine based compounds |
04/18/2007 | EP1773756A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
04/18/2007 | EP1773348A2 Tetrapeptide analogs |
04/18/2007 | EP1453792B1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease |
04/18/2007 | EP1425276B1 Heterocyclic carboxamides and their use as fungicides |
04/18/2007 | EP1406893B1 Pyrrolidine bicyclic compounds |
04/18/2007 | CN1950970A Material for electrolytic solution, ionic material-containing composition and use thereof |
04/18/2007 | CN1950393A Novel inhibitors of hepatitis c virus ns3 protease |
04/18/2007 | CN1950361A Pyrrole or imidazole amides for treating obesity |
04/18/2007 | CN1950351A 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
04/18/2007 | CN1948312A Preparation method of meluopeinan |
04/18/2007 | CN1948286A Salt of carboxylic acid containing N-substituted succinimide thio group and unvulcanized rubber composition containing the same |
04/18/2007 | CN1948285A Method of preparing 4-hydroxy pyrrolidone-2-acetylamine |
04/18/2007 | CN1310885C Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
04/18/2007 | CN1310884C Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-[(3S)-3-hydroxypyrrolidine-1-y1)ethyl]-2, 2-diphenyl acetamide |
04/18/2007 | CN1310689C Keratin fibre dyeing composition using cation direct dye and thickening polymer |
04/18/2007 | CN1310688C Keratin fibre hair dye composite containing cation direction dye and polymer thickening agent |
04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
04/17/2007 | US7205409 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomoderators |
04/17/2007 | US7205331 Pyrrole derivatives, for controlling plant diseases caused by fungal plant pathogens |
04/17/2007 | US7205330 can also modulate the processing of hepatitis C virus (HCV) polypeptide |
04/17/2007 | US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis |
04/17/2007 | CA2350073C Ccr5 modulators |
04/17/2007 | CA2273942C Process for the preparation of an organozinc reagent |
04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
04/17/2007 | CA2178642C Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
04/12/2007 | WO2007041724A1 N-substituted 3,4-alkylenedioxypyrroles, ester substituted dihydroxypyrroles and methods for synthesis of these pyrroles |
04/12/2007 | WO2007040682A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
04/12/2007 | WO2007040681A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
04/12/2007 | WO2007039749A2 Antibacterial pyrrols |
04/12/2007 | WO2007039736A1 Novel compounds |
04/12/2007 | WO2007039615A1 New n-alkyl-heterocyclyl carboxamide derivatives |
04/12/2007 | WO2007039404A1 Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles |
04/12/2007 | WO2007039403A1 Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors |
04/12/2007 | WO2007039183A1 Sythesis of renin inhibitors involving a cycloaddition reaction |
04/12/2007 | WO2007016385A3 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators |
04/12/2007 | WO2006114401A3 Novel cyclic amines |
04/12/2007 | US20070082943 Process for preparation of substantially pure glimepiride |
04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
04/12/2007 | CA2624501A1 Antibacterial pyrrols |
04/12/2007 | CA2623495A1 Synthesis of renin inhibitors involving a cycloaddition reaction |
04/12/2007 | CA2623348A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
04/12/2007 | CA2622673A1 Sulphonylpyrroles and use thereof as inhibitors of hdac s |
04/12/2007 | CA2622670A1 Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors |
04/11/2007 | EP1772452A2 Matrix metalloproteinase inhibitors and uses thereof |
04/11/2007 | EP1772449A1 New N-alkyl-heterocyclyl carboxamide derivatives |
04/11/2007 | EP1771455A2 Oxidative degradation products of atorvastatin calcium |
04/11/2007 | EP1771453A1 Hepatitis c inhibitor dipeptide analogs |
04/11/2007 | EP1771452A2 Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase |
04/11/2007 | EP1771438A1 1-3 substituted cycloamino derivatives and their use as histamine-3 receptor antagonists |
04/11/2007 | EP1771432A2 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
04/11/2007 | EP1771412A2 Crystalline forms of [r-(r*)]-2-(4-fluorophenyl)-bet a,gamma-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid calcium salt (2:1) |
04/11/2007 | EP1771411A1 Substituted 2-pyrrolidone derivatives as fungicides and insecticides |
04/11/2007 | EP1771409A1 N-acylated derivatives of dicarboxylic acids with amino acids and vegetable protein hydrolysates and their use in cosmetics and pharmaceuticals |
04/11/2007 | EP1771069A1 N-(2-(hydroxymethyl) phenyl)-1h-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials |
04/11/2007 | EP1771068A1 Substituted 1h-pyrrole-2,5-diones |
04/11/2007 | EP1351938B1 Phenyl derivatives |
04/11/2007 | EP1084107B1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
04/11/2007 | EP0885180B1 Stabilized monomer composition |
04/11/2007 | CN1946716A Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
04/11/2007 | CN1946688A Atorvastatin calcium in amorphous form |
04/11/2007 | CN1946687A Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin |
04/11/2007 | CN1946686A Method for preparing pyrrolidine oximes |
04/11/2007 | CN1946680A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
04/11/2007 | CN1944403A Process for recovering NMP in lithium cell membrance sheet drying process |
04/11/2007 | CN1943786A Ester compound and its medicinal application |
04/11/2007 | CN1309709C C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides |
04/11/2007 | CN1309413C Tetrapeptide derivative crystals |